Diabetes enhances the efficacy of AAV2 vectors in the retina: therapeutic effect of AAV2 encoding vasoinhibin and soluble VEGF receptor 1-Reference-Cited by-同舟云学术

Diabetes enhances the efficacy of AAV2 vectors in the retina: therapeutic effect of AAV2 encoding vasoinhibin and soluble VEGF receptor 1

Published:2015-11-16 Issue:3 Volume:96 Page:283-295
ISSN:0023-6837
Container-title:Laboratory Investigation
language:en
Short-container-title:Lab Invest

Author:

Díaz-Lezama Nundehui,Wu Zhijian,Adán-Castro Elva,Arnold Edith,Vázquez-Membrillo Miguel,Arredondo-Zamarripa David,Ledesma-Colunga Maria G,Moreno-Carranza Bibiana,Martinez de la Escalera Gonzalo,Colosi Peter,Clapp Carmen

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Link

http://www.nature.com/articles/labinvest2015135.pdf

Reference79 articles.

1. Boyer DS, Hopkins JJ, Sorof J et al. Anti-vascular endothelial growth factor therapy for diabetic macular edema. Ther Adv Endocrinol Metab 2013;4:151–169.

2. Vandenberghe LH, Auricchio A . Novel adeno-associated viral vectors for retinal gene therapy. Gene Ther 2012;19:162–168.

3. Ramirez M, Wu Z, Moreno-Carranza B et al. Vasoinhibin gene transfer by adenoassociated virus type 2 protects against Vegf- and diabetes-induced retinal vasopermeability. Invest Ophthalmol Vis Sci 2011;52:8944–8950.

4. Shyong MP, Lee FL, Kuo PC et al. Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vector. Mol Vis 2007;13:133–141.

5. Verma A, Shan Z, Lei B et al. Ace2 and Ang-(1-7) confer protection against development of diabetic retinopathy. Mol Ther 2012;20:28–36.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell and molecular targeted therapies for diabetic retinopathy;Frontiers in Endocrinology;2024-06-14

2. AAV-Based Strategies for Treatment of Retinal and Choroidal Vascular Diseases: Advances in Age-Related Macular Degeneration and Diabetic Retinopathy Therapies;BioDrugs;2023-10-25

3. The glucocorticoid receptor as a master regulator of Müller cell gliosis in the diabetic retina;2023-09-07

4. Levosulpiride for the treatment of diabetic macular oedema: a phase 2 randomized clinical trial;Eye;2023-09-06

5. Unconventional avenues to decelerate diabetic retinopathy;Survey of Ophthalmology;2022-11